ABEONA THERAPEUTICS INC.

Analyst Reco. Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
4.27 ^USD	-0.23%		-2.51%	-14.77%

May. 30	Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target	MT
May. 16	Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target	May. 30	MT
Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating	May. 16	MT
Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $40 From $22, Maintains Overweight Rating	22-11-08	MT
Alliance Global Starts Abeona Therapeutics at Buy With $20 Price Target	22-09-15	MT
SVB Securities Adjusts Price Target on Abeona Therapeutics to $5 From $1, Maintains Market Perform Rating	22-08-12	MT
Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $22 From $15, Reiterates Overweight Rating	22-08-12	MT
SVB Leerink Downgrades Abeona Therapeutics to Market Perform From Outperform; Price Target is $1	21-11-30	MT
HC Wainwright Adjusts Abeona Therapeutics' Price Target to $4 From $5, Keeps Buy Rating	21-11-29	MT
ABEONA THERAPEUTICS : HC Wainwright Adjusts Price Target on Abeona Therapeutics to $5 From $8, Maintains Buy Rating	21-07-19	MT
ABEONA THERAPEUTICS : HC Wainwright Adjusts Abeona Therapeutics' Price Target to $8 From $11, Keeps at Buy	20-11-25	MT
ABEONA THERAPEUTICS : B. Riley Adjusts Price Target on Abeona Therapeutics to $3 From $2, Reiterates Buy Rating	20-11-11	MT
ABEONA THERAPEUTICS : Cantor Fitzgerald Upgrades Abeona Therapeutics to Overweight From Neutral; Price Target is $4	20-11-11	MT
ABEONA THERAPEUTICS : SVB Leerink Adjusts Abeona Therapeutics PT to $5 From $8, Maintains Outperform Rating	20-11-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer